Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
United States
Children's Healthcare of Atlanta (Data Collection Only), Atlanta, Georgia Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York